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KLINEFELTER SYNDROME: THE EFFECTS OF EARLY HORMONAL 
INTERVENTION ON COMPETENCE AND BEHAVIORAL PHENOTYPE 
LAUREN CHEN 
ABSTRACT 
 Klinefelter syndrome (KS) (47,XXY) is the most common sex chromosomal 
anomaly in males with a prevalence of 1 in 650 males. This clinically relevant condition 
represents 3%–4% of the total patient population in male reproductive medicine 
practices. Klinefelter syndrome can manifest in different physical, cognitive, and 
behavioral phenotypes. The classical phenotypic descriptions are gynecomastia, 
hypotonia, tall stature, and hypogonadism. Currently there is no known treatment plan for 
adolescents who are diagnosed with this genetic condition. However, it has been 
hypothesized that early intervention through androgen replacement therapy can emulate a 
normal progression of puberty and improve the academic, social, and behavioral aspects 
of these adolescents.  
 Using standardized instruments, in the form of the Children Behavior Checklist 
(CBCL) and the Youth Self Report (YSR), we captured data on the patient’s competence 
and behavior, as well as the parents’ views on their child’s competence and behavior. 
These data were converted into percentile scores, T scores, and categorical data (normal, 
intermediate, and clinical). Difference of means was used to test for statistically 
significant differences between the scores of the KS patients and their parents on 
competence and behavioral aspects. T test for equality of means was run to determine if 
there was a significant difference between group scores. Pearson correlation tests were 
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done to see if there was an association between demographics of patients and 
competence/behavioral scores. We believed that there would be no statistically 
significant difference between how the parents score their child in the CBCL and how the 
child scores himself in the YSR in terms of demographics. We also believed that there 
would be no statistically significant difference or correlation between demographics and 
individual competence/behavioral scores. 
 A total of 39 groups of surveys were collected, together with demographic 
information on the maternal and paternal ages when the child was born, patient age, 
patient age when starting testosterone, patient age when starting anastrazole, and patient 
height and weight. We examined concordance frequencies in specific areas of the 
competence and behavioral questionnaires. Concordance was when the parent and the 
child agreed and evaluated the child as normal, intermediate, or clinical. Discordance was 
when the parents and the child disagreed; for example, the parent evaluated the child as 
“clinical,” but the child evaluated himself as “normal.”  
 This study, to our knowledge, is the first chart review study that involves a wide 
age range of males with KS. The study extends previous findings by providing data on 
how early hormonal intervention can improve the outlook of these patients’ lives. When 
taking aromatase inhibitors, the KS adolescents showed an overall reduction of 
aggression and rule-breaking behavior. When taking testosterone at an earlier age, the 
patient was less likely to have withdrawal depression. We also found the most 
discordance in total competence scores, suggesting that some parents may have 
unrealistic academic expectations for their child. Thus, when examining the data, we had 
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to be aware that there were varying views of success, which can shape how parents and 
child answer their respective surveys.  
 Our findings demonstrate the significance of early detection and treatment of 
Klinefelter syndrome, a disorder that is severely under-diagnosed throughout the world. 
The results also show that the desire of parents for their KS child to do well in school 
may affect their opinions on how their child is actually performing. Some limitations to 
this study include the decision to receive early hormonal intervention that was made 
exclusively between parents and their urologist. Furthermore, the socioeconomic status 
(SES) and educational characteristics of the families were not properly controlled, 
although the patient population was mostly likely similar because of the location of the 
clinic.  
Future Klinefelter syndrome studies will need to focus on identifying the factors 
that contribute to the variability of behavioral symptoms. In turn, these studies will 
support the continuing development of evidence-based treatments for adolescents with 
Klinefelter syndrome.  
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INTRODUCTION 
 	 Klinefelter syndrome (KS) (47,XXY) is the most common sex chromosomal 
abnormality in males, with a prevalence of 1 in 650 males (Samango-Sprouse, 2015). KS 
is also clinically relevant in male reproductive medicine practices; the condition 
represents 3%–4% of the infertile patient population. Although there is considerable 
variation in physical phenotype among affected patients, the classical phenotypic 
descriptions are gynecomastia, hypotonia, tall stature, hypogonadism, and central obesity. 
In addition to these medical features, the presence of the extra X chromosome can lead to 
characteristic cognitive, social, and language deficits ranging from mild to severe (Boada 
et al., 2009). Early intervention through androgen replacement therapy, occupational 
therapy, physical therapy, and speech therapy has been associated with decreased obesity 
rates and improved academic and social aspects of adolescents with KS (Samango-
Sprouse et al., 2013; Samango-Sprouse et al., 2015). Early detection of this genetic 
condition and constant management with early androgen therapy have been shown to 
improve overall health, academic progress, and social integration for many patients with 
KS. 
 
History on Discovering Klinefelter Syndrome  
 The research on various phenotypic features of individuals with KS developed 
over three stages (Boada et al., 2009). Dr. Klinefelter first described the syndrome in 
1942, and a discovery by Dr. Jacobs in 1959 identified the etiology of the condition to be 
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the presence of an extra X chromosome (Jacobs et al., 1959; Klinefelter et al., 1942). 
Later on, other investigators described increased rates of cognitive disabilities and other 
mental health problems in patients with the extra X chromosome. However the validity of 
these studies is controversial because the patient groups originated from mental health 
hospitals or long-term care facilities for developmentally challenged people (Bourgeois & 
Benezech, 1977; Eriksson, 1972; Johnston et al., 1974; Singh et al., 1974). Consequently, 
these cognitive studies were highly criticized as a result of potential bias, but they 
initiated the investigation of cognitive and genetic differences in XXY individuals.  
 In the next stage of research studies on males with KS, investigators tried to 
address the bias in prior studies. Newborns were screened for the 47, XXY genotype and 
were followed through adulthood. Many sites, such as Toronto, Denver, and Edinburgh, 
participated in this study; they pooled their findings and aggregated results at a global 
level (Netley, 1986; Ratcliffe et al., 1990; Robinson et al., 1990). These prospective 
studies shaped the current knowledge of KS in terms of developmental, physical, 
cognitive, and behavioral characteristics. One important finding was that patients with 
KS had a better cognitive outlook than stated in the earlier literature. These studies 
improved upon previous studies because they selected patients from birth, they were 
prospective, and they had a long-term follow-up. Many of the studies also tracked the KS 
male sibling(s) as a control group to avoid confounding variables from socioeconomic 
status (SES), parenting styles, and other environmental factors. However, the cohorts 
were relatively small—the Toronto study had 31 patients, Denver had 15 patients, and 
Edinburgh had 19 patients. Considering the prevalence of KS in the general population, a 
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more robust sample size was needed in future studies.  
 The third stage of studies began after the prospective studies and focused more on 
cognitive characteristics clinically presented in men with KS. This work included 
neuropsychological studies and studies that correlated cognitive outcomes to genetics 
(Boone et al., 2001; DeLisi et al., 1994; Ross et al., 2008; van Rijn et al., 2006; Zinn et al, 
2005; Zitzmann et al., 2004). From these studies, researchers determined that not all 
males with KS are negatively affected cognitively, and that a large portion of the KS 
population was highly successful in academics and in future careers. However, these 
studies also determined that there was a subgroup of KS males that had 
neuropsychological impairment related to the extra X chromosome (Boada et al., 2009). 
Future studies were recommended to develop better treatment options, as well as identify 
the specific gene on the X chromosome that was responsible for the subgroup’s cognitive 
impairment. 
 
Genetic Factors  
 There have been many theories as to how genetic factors are linked to the various 
types of phenotypes that appear in KS. These factors include the following: mosaicism, 
polymorphisms of specific genes on the X chromosome, parent-of-origin of the extra X 
chromosome due to imprinting differences or X chromosome isodisomy, and gene-
dosage effects of X chromosome genes that escape X inactivation (Geschwind et al., 
2000).  
 Mosaicism applies to individuals who have different populations of cells. In KS 
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this can appear as 46,XY/47,XXY; 47,XXY/48,XXXY; or other variations. The most 
common mosaicism in KS is 46,XY/47,XXY. Patients with this type of mosaicism seem 
to have better fertility rates than their non-mosaic counterparts (Seo et al., 2006; Steward 
et al., 1990).  However, when comparing males with 46,XY/47,XXY mosaicism and non-
mosaic KS males, researchers failed to find a significant difference in cognitive skills 
(Netley, 1986; Stewart et al., 1990). There have been reports that those who have 
tetrasomy and/or pentasomy mosaicism showed more cognitive deficits than those with 
47,XXY due to the tetrasomic cell line. Therefore, it is generally accepted that mosaic 
patients with 46,XY have less KS characteristics than non-mosaic patients and that 
mosaicism with tetrasomy and/or pentasomy has more significant cognitive impairments. 
 Genetic polymorphism of specific genes on the X chromosome has been 
hypothesized as the reasoning behind phenotypic variability in KS males. In particular, 
the androgen receptor (AR) is of interest because of androgen deficiency that is present in 
KS males. The AR gene is polymorphic in the number of CAG (cytosine-adenine-
guanine) repeats in the coding region, and the length of CAG repeats is inversely 
correlated to how responsive the receptor is to testosterone (Zitzmann, 2009). It has been 
hypothesized that KS males who have an AR receptor with less CAG repeats may have 
improved responses to circulating androgen and less severe KS phenotypic 
characteristics. Zitzmann found that men with KS and longer CAG repeats in the AR 
exhibited more significant physical features of KS (gynecomastia, tall stature), had social 
retardation, lacked professional employment, and were not as likely to be in a long-term 
relationship. This suggests that short CAG repeats in the AR are linked to less significant 
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physical features and improved social outcomes. Following Zitzmann’s work, two 
subsequent studies failed to find the link between CAG repeat length and cognitive skills 
(Ross et al., date; Stemkens et al., 2006). However, these studies were done on 
populations that differed in age and androgen exposure, and these two factors could affect 
receptor responsiveness in patients. 
 Parent-of-origin of the extra X chromosome has been studied to see if phenotypic 
variability may be related to an imprinted sex chromosome locus (Boada et al., 2009). 
Such imprinting may lead to differentially expressed maternal or paternal alleles resulting 
in the expression of X-linked recessive genes. For example, in girls with Turner 
syndrome (45,X) the parent-of-origin of the single X chromosome affects the phenotype. 
Turner girls who have maternally inherited X chromosome are more likely to be socially 
awkward and have autistic behavior than those who have paternally inherited X 
chromosome (Skuse et al., 1997). KS men with XXY have the extra X chromosome 
maternally inherited in 50%–60% of the cases (Hassled et al., 2007; Thomas & Hassold, 
2003). Studies have generally agreed that the parent-of-origin of the extra X chromosome 
has no significant effect on cognition (Jacobs et al., 1988; Ratcliffe et al., 1991; Ross et 
al., 2008; Stemkens et al., 2006), motor skills (Ross et al., 2008), or other psychiatric 
issues (Boks et al., 2007). Also, if parent-of-origin did affect cognition, there would be a 
more bimodal distribution within the KS population to show maternal versus paternal 
origin rather than the well-known normal distribution developed by Bender in 1986. 
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Figure 1: Estimated Full-Scale IQ (FSIQ) distribution for children with 47,XXY 
compared to controls. There is a standard distribution of IQ scores, with a normal curve 
shifted to the left with the mean FSIQ at 91. Adapted from Bender, 1986a.  
 
 
 
 
 
 Overexpression of genes that escape X inactivation has also been hypothesized to 
affect physical features and varying cognitive phenotypes in KS (Geschwind et al., 2000; 
Linden et al. 1995; Rappold, 1993). 20% of X chromosome genes escape X inactivation, 
and a large portion of those genes are located in the pseudoautosomal regions (PAR) of 
the X and Y chromosomes (Cooke & Smith, 1986; Vogt et al., 1997; Willard et al., 
1996). Most of the genes in the PAR regions are expressed and not inactivated. 
Therefore, in 47,XXY all three sex chromosomes have the genes expressed, and in KS 
males there were differences seen in PAR gene expression (Geschwind et al., 2000). 
Using microarray technology, Vawter et al. (2007) identified 129 differentially expressed 
genes, including 14 of which were X chromosome and 12 of which showed a significant 
relationship with verbal cognitive abilities. 
 
Physical Development Outcomes 
 KS patients have variable physical phenotypes that may or may not manifest 
	7 
during pubertal stages. Therefore, it may be hard to physically distinguish between these 
patients and other males with the traditional XY karyotype (Caldwell & Smith, 1972). 
Because there are no distinct physical features, there is a delay in diagnosis at birth and 
during infancy; affected toddlers have normal heights and weights. Even though a 
micropenis is sometimes seen in boys with KS, it is not considered a diagnostic trait of 
KS and is rarely enough of a reason to perform a karyotype. Small testicular size, 
however, is an indicative symptom of KS, though the difference in testes size does not 
become apparent until at least Stage II of the Tanner Scale (a system used to determine 
physical development in adolescents).  
 
Figure 2: Tanner scale. This is a scale of physical development in children, adolescents 
and adults. It defines physical measurements of development based on external primary 
and secondary sex characteristics. Adapted from 
https://en.wikipedia.org/wiki/Tanner_scale. 
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 The most consistent characteristic seen in prepubescent KS boys is a small delay 
in the ability to walk by the age of 2–4 months as a result of hypotonia (Paduch, 2012). 
This condition will elicit a cytogenetic evaluation, which will eventually lead to the 
diagnosis of KS. The lack of physical characteristics to diagnose toddlers and infants with 
KS has proved to make an early diagnosis difficult. Paduch (2012) suggests for 
pediatricians to look for subtle findings such as hypotonia, disproportional height, and 
delay in milestones compared with the KS patient’s male siblings.  
 Although it is hard to diagnose boys with KS pre-puberty, the typical physical 
traits become more apparent when the patients reach early adolescent years.  Younger KS 
adolescents often have attention and behavioral problems, whereas older adolescents 
have issues with motor performance (Ross et al., 2008). Verri et al. (2010) found that 
with specific motor tasks, such as finger or foot tapping, boys with KS performed close to 
average levels; however, as the tasks became more complicated, the KS males failed to 
perform on the same level as the control group of XY males. These motor difficulties are 
not only of academic interest, but they also have psychosocial implications as well. KS 
males, who have less than average athletic ability combined with the typical disposition 
of excessive shyness and impulsivity, may have their social life and mental health 
negatively affected by their condition (Paduch, 2012). As a result of an early diagnosis, 
early intervention with androgen replacement therapy may not only improve physical 
performance, but also result in better social integration at school.   
 Males with KS have abnormal height; by the age of 7, over 50% of the boys will 
exceed the 97th percentile of height for their age group. The increase in height is most 
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significant between the ages of 5 and 8 and is due to elongated limbs (Ratcliffe, 1999; 
Schibler et al., 1974). Tall stature is a characteristic typical of young men with KS. The 
mechanism behind this is unclear, but it has been hypothesized that there is insufficient 
estrogen to close the epiphyseal plate in these boys. Although most KS men have 
hyperestrogenism, it is not certain when the onset of this increase in estrogen occurs. 
Also, most KS males are taller than expected prior to puberty, so it is unlikely that 
hormones play a dominant role in height for KS patients. According to Paduch’s review 
of patient growth charts (2012), the mean height appears to peak and plateau at age 17. 
However, weight changes in KS adolescents lag behind height changes, and a weight 
plateau is achieved 7 years after the height plateau (Paduch, 2012). Additionally, Paduch 
found that body mass index (BMI) is a less reliable measure of childhood obesity in KS 
because the increased height artificially lowers BMI. Instead, he suggests the Tanita 
InnerScan Body Composition Monitor Scale (Tanita Corporation of America, Arlington 
Heights, IL) to directly assess body fat percentage in KS patients.  
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Figure 3: Height and weight distribution of patients seen at Paduch’s practice. This 
cohort consists of 135 adolescents. Adapted from Paduch, 2012.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sexual Development Outcomes 
 KS individuals typically initiate puberty at the same age as the general population, 
but they have delays in facial hair development and muscle development compared with 
their siblings. Penile growth is typically not affected, but the girth may be. In Paduch’s 
practice at Weill Cornell Medicine (New York, NY), KS patients (48,XXXY) have a 
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characteristic thickening of penile skin that causes the penile circumference to exceed the 
length. Scrotal development is normal, but as puberty progresses, testicular size is 
significantly decreased. In patients with KS, testicular volume dramatically decreases by 
Tanner stage IV, which predicts that the atrophy of testes occurs between Tanner stages 
II and III (Paduch et al., 2009). Decrease in testicular volume is also caused by damage to 
the germinal epithelium as well as peritubular fibrosis (Bolyakov & Paduch, 2011). It is 
interesting to note that the size of the epididymis does not change during pubertal 
development and remains the same as normal XY counterparts (Bolyakov & Paduch, 
2011). 
 As previously stated, many KS adolescents enter puberty around the same age as 
the general population, but testosterone concentrations decline at late adolescence and 
early adulthood. Because of decreased androgen production, characteristics such as 
facial, body, and sexual hair do not develop, whereas features of eunuchoidism and 
gynecomastia can potentially develop. As a result, KS adolescents and KS men in their 
early twenties look much younger than their chronological age. The incidence rate of 
gynecomastia in KS ranges from 56% to 88% (Smyth & Bremner, 1998). Although 
testosterone levels are low, adolescents with KS start masturbation at a similar time to the 
general population. However, KS adolescents experience a significant delay in the age of 
first voluntary ejaculation. In healthy adolescents, the mean time difference from the age 
of first masturbation to the age of ejaculation is 2 months, but in KS adolescents, the 
delay is 9 months (Bolyakov & Paduch, 2012). This delay may occur because the S2-S4 
region of the spinal cord, which is responsible for ejaculation, is sexually dimorphic and 
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is highly dependent on adequate levels of testosterone (Bolyakov & Paduch, 2012). 
 All KS patients are considered infertile, though there have been reports of 
pregnancy without assisted reproductive technology (ART). These cases are believed to 
have only occurred in mosaic KS men. With the introduction of new technology, such as 
intracytoplasmic sperm injection (ICSI), some KS fathers have an increased chance of 
fathering a child (Kaplan et al., 1963; Okada et al., 1999; Ron-El et al., 2000; Schiff et 
al., 2005). A study done by Schiff (2005) consisting of 42 KS men showed that the sperm 
retrieval rate was 72% for each testicular sperm extraction (TESE) attempt and that 69% 
of the patients achieved pregnancy using ICSI. Therefore, TESE and ICSI may be 
considered a good alternative for men with KS who want to reproduce. According to 
Paduch (2012), one should allow the patient to deliver semen samples by masturbation to 
initially check for sperm in the ejaculate before proceeding to surgical treatment options.  
 
Cognitive Outcomes  
 Unlike other chromosomal aberration syndromes such trisomy 21, KS men 
generally are not in the intellectual disability range (Boada et al., 2009). Studies have 
found that the mean cognitive ability of patients with KS falls in the low-average to 
average range (Boada et al., 2009). Lower scores are believed to be due to deficits in the 
verbal aspect of cognitive ability rather than the nonverbal or spatial aspect (Boada et al., 
2009).  
 Longitudinal studies that were conducted with KS children revealed differences in 
verbal IQ (VIQ) scores and performance IQ (PIQ) scores. The discrepancy between 
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verbal and performance scores was evident even at a young age (Pennington et al.,1982; 
Samango-Sprouse et al., 2001), and both verbal and nonverbal skills diminished over 
time (Bender et al., 1993). Furthermore, Boone (2001) found that as KS patients grew 
older, the VIQ score increased relative to PIQ, and that VIQ was no longer a deficit when 
the patient grew older. This may be a result of hormonal imbalances during puberty. 
Others have speculated that this may reflect a correlation between language processing 
ability and androgen treatment in adult patients (Boada et al., 2009). It may also be that 
PIQ decline in older KS patients is happening more rapidly than normal deterioration 
(Boada et al., 2009).  
 Outside confounding factors such as socioeconomic status (SES) can have an 
effect on the cognitive outcomes of patients with KS. Through correlation twin studies, it 
has been observed that differences in intelligence appear to vary with the SES of homes 
in which the children were raised in (Turkheimer et al., 2003). When parents with higher 
SES are told of their child’s diagnosis with KS, they proceed with the pregnancy despite 
this diagnosis (Boada et al., 2009). They are prepared when the child is born and are 
ready to increase the number of resources available for the child. Although most children 
with KS show developmental delays, a cohort of children received a mean IQ of 110, 
which is considered in the high average range, because their parents were part of the 
upper middle class and provided them with extra means (Samango-Sprouse, 2001).  
 Overall, there is significant variability when it comes to the cognitive outcome of 
children and adults with KS. Language and academic deficits appear to affect verbal 
skills, but these deficits seem more prominent in younger ages. Multiple outcome studies 
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have reported less of a discrepancy between VIQ and PIQ, and there are multiple 
working factors, such as SES, that determine what the ultimate cognitive function is for 
KS patients (Boada et al., 2009). Although some patients have above average or superior 
cognitive abilities, the proportion of men with KS who have these high levels of 
cognitive abilities are less than those in the general XY population. 
  
Language and Reading Competence  
 In addition to general cognitive deficits, KS children and adults have specific 
difficulties with language and reading. These difficulties have been identified in 70%–
80% of children (Boada et al., 2009), with delays in speech starting as early as 24 months 
of age (Robinson et al., 1990). Most of the difficulties stem from expressive language, 
but receptive language deficits were also noted. Moreover, KS patients have issues with 
phonemic discrimination, processing speeds, sentence verification tasks, and 
comprehension of language (Bender et al., 1993; Graham et al., 1988; Netley et al., 1982; 
Rovet et al., 1996; Walzer et al., 1990). Tasks with increased perceptual discrimination or 
short-term memory demands are activities that KS patients struggle with most. Auditory 
processing and verbal memory are the main cognitive deficits that are linked with these 
difficulties (Geschwind & Dykens, 2004). Furthermore, these language deficits are 
identified throughout adulthood with greater impairment to verbal memory, auditory 
memory, confrontation naming, and verbal fluency skills than in the control group 
(Bender et al., 1993; Boone et al., 2001; Gerschwind et al., 1998) 
 KS individuals also demonstrate deficits throughout their academic careers. KS 
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children represented a good proportion of patients who receive special education support, 
especially in language and spelling (Pennington et al., 1982; Robinson et al., 1986). 
Approximately 50%–75% of KS boys have shown a reading disability at some point in 
their development (Bender et al., 1986; Graham et al., 1988). Similar to language 
difficulties, overall academic difficulties in patients with KS continue throughout 
adulthood. About 70% of KS adults show evidence of reading disabilities (Boone et al., 
2001; Geschwind et al., 2004). 
 As studies examined academic achievements in KS children, some authors have 
reported that the gap is not only limited to literacy; there is a group of KS patients who 
have an overall learning disability. Some KS children scored significantly lower 
compared to their sibling controls on math. By 18–20 years of age, KS children lagged 
more than five grade levels behind the control group in both reading and math (Rovet et 
al., 1996). 
 Although it is generally said that KS patients have a weakness in verbal and 
language skills, there is significant variance among KS males in language deficits similar 
to physical phenotypes. It has been reported that there is no difference between verbal 
and nonverbal reasoning skills, with both of these scores being in the low average to 
average range (Netley et al., 1986; Ross et al., 2008). It was also shown that KS patients 
were in the average range on literature and arithmetic skills. In addition, the academic 
performance of KS patients did not decline with age. 
 There have been inconsistencies within findings in the language domain. 
Although receptive language skills have been described as deficient in KS, Graham et al. 
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(1988) reported that their cohort scored within normal range on all receptive language 
skills except for one measuring syntactic comprehension. Bender (1993) reported no 
significant difference in ability to understand syntactical complexity, and Ross et al. 
(2008) did not find evidence of expressive or receptive vocabulary problems in their 
cohort of KS patients. Given the range of phenotypic severity in KS, the variability of 
conclusions across these studies is not surprising.  
 
Genetic and Hormonal Factors Affecting Cognition  
 Although it is generally known that children with KS have learning deficits, there 
are still questions regarding the severity of these deficits. Additionally, the relationship 
between phenotypic variability and having an extra X chromosome or androgen 
deficiency is still unclear. Most verbal cognitive delays are present in sex chromosome 
trisomy diseases that are not typically associated with hormonal deficiency (47, XYY and 
47, XXX), so it is likely that genetic factors play a bigger role in cognitive phenotype 
than hormonal factors, especially since cognitive deficits occur early in childhood prior to 
the onset of hormonal deficiencies. Furthermore, neuroanatomical differences in the 
temporal and front lobe volumes are present in KS children when compared with the 
control (Giedd et al., 2007). These findings support the argument of a genetic etiology. 
Although there have been studies done that suggest there may be a hormonal deficiency 
in KS neonates (Lahloud et al., 2004; Ross et al., 2005), another study by Aksglaede et al. 
(2007) reports that there is increased testosterone in KS children when compared with the 
control group. In order to clarify these conflicting results, better assays that accurately 
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measure testosterone levels will need to be utilized to determine if pre-pubertal androgen 
is at deficient or increased levels in KS children (Boada et al., 2009).  
 There is little argument that there are differences in androgen levels in KS males 
compared with the control group during young adulthood (Aksglaede et al., 2008; 
Winter, 1990). A time of their life where cognitive and neuropsychological differences 
are present. In normal children, androgen levels have been shown to be positively 
correlated with spatial abilities and negatively correlated with language abilities 
(Knickmeyer et al., 2005). Therefore, if cognitive skills in KS were related only to 
androgen deficiency, one would see decreased spatial abilities relative to language skills, 
which is not the case (Boada et al., 2009). However, early androgen levels do play a role 
in neurodevelopment (Friederici et al., 2008; Mercure et al., 2009; Swedloff et al., 1992), 
so more studies are needed to understand pre-pubertal androgen in KS children and its 
effect on cognition phenotype. Also, since neurodevelopment continues into early 
adulthood, there may be important effects of androgen deficiencies on the maturing brain 
of men with KS (Giedd et al., 2006; Lenroot & Giedd, 2006).     
 
Management Through Androgen Replacement Therapy  
 The management of KS combines counseling, special education, and testosterone 
replacement therapy (TRT). Androgens can induce the development of male secondary 
characteristics, eliminate gynecomastia, and improve general behavior and work 
performance (Landin-Wilhelmsen et al., 1999; Ruvalcaba et al., 1989). TRT should begin 
at puberty and increase in dosage to maintain age-appropriate testosterone, estradiol, 
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follicle-stimulating hormone (FSH), and luteinizing hormone (LH) serum concentrations. 
TRT normalizes body proportions and male secondary characteristics; however, it does 
not treat infertility and small testes. The long-term benefits of TRT include reducing the 
risk of osteoporosis, autoimmune disease, and breast cancer (Mehta et al., 1993), 
promoting male phenotype development, increasing penile size, improving cognition, and 
decreasing gynecomastia and abdominal obesity (Wosnitzer et al., 2013).  
 In the past, testosterone was given intramuscularly, but this was proved to be 
inefficient because it required painful injections, visits to the pediatrician to administer 
the injection, and excessive levels of testosterone in the KS patient. These high levels 
contribute to the increase in blood concentration and the suppression of follicular 
stimulating hormone (FSH) and luteinizing hormone (LH) to undetectable levels. 
Consequently, topical testosterone is preferred because it achieves physiological levels of 
testosterone without suppressing FSH and LH. The topical testosterone has high 
compliance among the adolescent population (Mehta et al., 2014). TRT should be 
monitored at six weeks to determine how the patient is feeling, and the dosage should be 
adjusted every six months as determined by the progression of puberty.  
 KS is also associated with hyperestrogenism. This condition is most likely due to 
the increased adipose tissue present in KS patients as well as the increased activity of 
aromatase CYP19, an enzyme that converts testosterone to estrogen (Bolyakov & 
Paduch, 2012). Aromatase inhibitors such as anastrazole are helpful in adolescents with 
gynecomastia and central obesity that do not respond to topical testosterone. These 
aromatase inhibitors are used for one to two years, but not much longer because of the 
	19 
risk of osteopenia. Overall, the early intervention of TRT results in improved academic, 
physical, psychological, and social development.  
 
Specific Aims/Objectives  
 Androgen deficiency is a common characteristic in KS patients; however, there is 
minimal clinical data on the effects of testosterone therapy on psychological and 
cognitive features in KS males. Past studies have shown that early androgen treatment for 
patients diagnosed with Klinefelter syndrome, results in better self-esteem, attention, 
energy level, and general well-being (Gerschwind et al., 2004; Neilsen et al., 1987; 
Simpson et al., 2005). 
 This study aims to show that adolescents who are treated with testosterone and 
aromatase inhibitors during early-onset puberty will overcome the social, cognitive, and 
behavioral difficulties that are usually associated with this condition. In addition, we will 
compare this study to previous literature on KS behavioral phenotypes. Finally, we will 
assess the parent’s views on their child’s competence, internalizing, externalizing, and 
overall behavior score versus that of the child’s own self-reflection.  For our study 
population, we will utilize the patient population of Dr. Darius A. Paduch at Weill 
Cornell Medicine (New York, NY).  
 The specific aims of the study are: 
1. To determine if early hormonal intervention will alleviate the social, 
educational, and behavioral difficulties that Klinefelter syndrome boys usually 
encounter. 
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2. To characterize the behavioral phenotypes of Klinefelter syndrome adolescents 
seen at Weill Cornell Medicine and to compare these phenotypes to those 
described in the previous literature. 
3. To assess how parental views on their child’s social life, schoolwork, and 
behavior differ from the child’s own self-reflection on these various aspects.  
 Through this study we hope to eliminate the current stigma that the medical 
community has about KS. We hope to establish an understanding that with early 
hormonal intervention, boys diagnosed with this syndrome will be able to lead relatively 
normal lives as compared with the general population. We also hypothesize that parents 
put pressure on their child to perform to the best of his abilities and that there will be 
discordance between the parents’ view of their child and the child’s view of himself.  
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METHODS  
Participants 
 Participants were recruited for research participation from the Urology 
Department at Weill Cornell Medicine, specifically the practice of Darius A. Paduch 
M.D., Ph.D. The study was approved by the Institutional Review Board (IRB) at Weill 
Cornell Medicine. The clinical evaluation was performed at Weill Cornell Medicine, and 
confirmatory karyotyping was carried out by the Male Infertility Laboratory at Weill 
Cornell Medicine. 
 
Assessment Procedures 
 Patients received a physical examination during their regularly scheduled office 
visits. At this clinical office visit, maternal age and paternal age at the time of child’s 
birth was ascertained. The competence/behavioral questionnaire was done either online 
through a secure network or at an office visit. The questionnaires were distributed from 
January 2016 to March 2016. Medication regimen and age when beginning the 
medication were extracted from the patient’s electronic medical record (EMR).  
 
Anthropometric Measurements 
 The clinical assessment included measurements of height in inches and weight in 
pounds. Pubertal development was assessed by an experienced urologist who specialized 
in seeing children with Klinefelter syndrome. Tanner stage was not measured, as most of 
the study subjects were past puberty and did not have a current Tanner stage documented. 
This information was extracted from each participant’s EMR.  
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Parent Questionnaires 
 The Child Behavior Checklist (CBCL) is a standardized measure of behavior 
problems and social competency in children ages 2 to 18 years and includes t scores for 
10 problem behavior areas and 3 social competency areas (activities, social skills, and 
school). The behavior problem scales include internalizing behavior (anxiety depression, 
withdrawn depression, and somatic complaints), externalizing behavior (rule breaking 
and aggression), and total behavior domain scores. For the social competency areas, 
higher scores are considered good, whereas for the behavior problem scales, higher 
scores are considered bad.  
 For the social competency results, percentile nominal scores were converted into 
categorical data. Percentile scores above 7 were considered normal, percentile scores 
below 2 were considered clinical, and percentile scores between 2 and 7 were considered 
intermediate. The total competence T score was also converted into categorical data. T 
scores above 40 were considered normal, T scores below 37 were considered clinical, and 
T scores between 37 and 40 were considered intermediate. This categorical scale was pre-
determined on the standardized instrument’s scoring sheet.  
 For scoring the problem behavioral results, any percentile scores below 50 as a T 
score were converted to 49, and any percentile scores above 93 were converted to 94. 
This was done in order to standardize the scores that were considered below or above the 
scale provided by ASEBA (Achenbach System of Empirically Based Assessment). 
Nominal data were also converted into categorical data. For problem behavior areas, 
percentile scores above 98 were considered clinical, percentile scores below 93 were 
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considered normal, and percentile scores between 93 and 98 were considered 
intermediate. For total T scores that covered internalizing, externalizing, and total 
behavior domain scores, T scores below 60 were considered normal, T scores above 63 
were considered clinical, and T scores between 60 and 63 were considered intermediate.  
 
Child Questionnaires  
 The Youth Self Report (YSR) is a standardized measure in child psychology and 
was derived from the CBCL. The YSR was designed to evaluate the emotional and 
behavioral problems in adolescents. The measure assesses internalizing behavior 
(anxiety, depression, and somatic complaints) and externalizing behavior (rule breaking 
and aggression). There are also different subscale symptoms that measure eight 
empirically based syndromes. The measure assesses total competency using a scale that 
comprises competency in activities, social functioning, and school performance. For the 
competency areas, higher scores are considered good, whereas for the behavior problem 
scales, higher scores are considered bad. 
 For the social competency results, percentile nominal scores were converted into 
categorical data. Percentile scores above 7 were considered normal, percentile scores 
below 2 were considered clinical, and percentile scores between 2 and 7 were considered 
intermediate. The total competence T score was also converted into categorical data. T 
scores above 40 were considered normal, T scores below 37 were considered clinical, and 
T scores between 37 and 40 were considered intermediate.  
 For scoring the problem behavioral results, any percentile scores below 50 as a T 
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score were converted to 49, and any percentile scores above 93 were converted to 94. 
This was done in order to standardize the scores that were considered below or above the 
scale provided by ASEBA. Nominal data was also converted into categorical data. For 
problem behavior areas, percentile scores above 98 were considered clinical, percentile 
scores below 93 were considered normal, and percentile scores between 93 and 98 were 
considered intermediate. For total T scores that covered internalizing, externalizing, and 
total behavior domain scores, T scores below 60 were considered normal, T scores above 
63 were considered clinical, and T scores between 60 and 63 were considered 
intermediate. 
 
Genetic Testing 
 To confirm diagnosis, a peripheral blood karyotype was obtained, or previous 
medical records from doctors outside of Weill Cornell Medicine were evaluated. If a 
karyotype was obtained at Weill Cornell Medicine, a sample of blood was drawn. Cells 
from the blood are centrifuged, cultured, treated with reagents, and finally dropped on a 
microscope slide to dry. These slides are stained to induce a banding pattern and then 
photographed. A lab technician analyzed the image by using computer software that 
arranges the chromosomes in order of size.  
 
Concordance 
 For concordance between parent and child frequencies, we decided to examine 
specific aspects of the competence and behavioral questionnaires. Results were 
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considered concordance if the parent and child both agreed and evaluated the child as 
either “normal,” “intermediate,” or “clinical.” Results were considered discordance if the 
parent and child disagreed and evaluated the child differently; for example, if the parent 
evaluated the child as “clinical,” but the child evaluated himself as “normal.”  
 We chose to focus our study more on anxiety depression, withdrawn depression, 
total competence, internalizing behavior, externalizing behavior, and total behavioral 
score. The total competence encompassed social skills, schoolwork, and the number of 
activities in which the child was involved. Internalizing behavioral scores included 
anxiety depression, withdrawn depression, and somatic problems. Externalizing 
behavioral scores included aggressive behavior and rule-breaking behavior. Finally, total 
behavioral score included internalizing behavioral aspects, externalizing behavioral 
aspects, and also social problems, thought problems, and attention problems. 
 
Statistics 
 Raw scores were converted into percentile scores and t scores (mean of 50; SD of 
10) are based on test-specific norms. Percentile scores and T scores were then converted 
into categorical data (clinical, intermediate, and normal). Difference of means was used 
to test for statistically significant differences between the scores of the KS patients and 
their parents on competence and behavioral aspects. Significant differences between 
group scores were determined using the t test for equality of means since normality was 
present. P values <0.05 were considered statistically significant. Pearson correlation tests 
were also run to see if there was an association between demographic variables and 
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competence/behavioral scores. 
 The first null hypothesis was that there was no statistically significant difference 
between how the parents score their child in the CBCL and how the child scores himself 
in the YSR in terms of demographics. The second null hypothesis was that there was no 
statistically significant difference or correlation between demographics and raw 
individual competence and behavioral scores. 
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RESULTS 
Study Population 
 A total of 39 subjects were enrolled, resulting in 33 CBCLs and 31 YSRs 
collected. Some groups did not have one of the two questionnaires filled out, and this was 
indicated as “missing” when analyzing the data. Patient and parental demographic 
information is presented in Table 1. The mean maternal and paternal ages were 
34.76±5.41 and 37.41±5.91 years old, respectively. The average age of patients who 
completed the questionnaire was 19.05±6.54 years old, with an age range of 6–40 years 
old. The average age of patients when they started taking anastrazole, more specifically 
Arimidex, was 16.66±5.72 years old. The average age for TRT initiation was 14.38±4.72 
years old. The average height of patients was 69.82±5.86 inches, and the average weight 
was 155.13±43.17 pounds. Using the average height and average weight, there is a 
calculated value of 22.26 for BMI.  
 
Table 1: Demographics of patient population. 
 
Age 
(years) 
N= 39 
Age when 
starting 
Arimidex 
(years)  
N= 32 
Age when 
starting 
Testosterone 
(years) 
N= 39 
Height 
(inches) 
N= 39 
Weight 
(pounds) 
N= 39 
Paternal 
Age 
(years) 
N= 32  
Maternal 
Age 
(years) 
N= 33 
Mean  19.05 16.66 14.38 69.82 155.13 37.41 34.76 
Std. Dev. 6.540 5.720 4.720 5.860 43.170 5.910 5.410 
Minimum 6 10 4 45.00 45 28 26 
Maximum 40 36 32 76.77 270 51 44 
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Adult Questionnaire Evaluation 
 CBCL categorical competence results are shown in Figure 4. We excluded 
missing data from 6 questionnaires because 6 patients filled out the YSR while their 
respective parents did not fill out the CBCL. For activities, 81.8% of parents believed that 
their child was considered normal for his age group. For social skills, 78.8% of parents 
believed that their child was considered normal for his age group. For school, 36.3% of 
parents believed that their child was having trouble with schoolwork and was not doing 
well in school work. These results were in turn reflected in total competence. Only 48.5% 
of parents believed that their child was considered normal, and 51.5% believed that their 
child was considered intermediate or clinical in terms of competence. The areas of 
competence and behavior that were most clinical are: total competence, total behavior, 
and internalizing behavior.  
Figure 4: CBCL categorical competence and behavioral results (N = 33).  
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Child Questionnaire Evaluation 
 YSR categorical competence results are presented in Figure 5. We excluded 
missing data from 8 questionnaires because 8 parents filled out the CBCL while the 
respective patient did not fill out the YSR. For activities, 87.1% of patients believed that 
they were normal and participated in enough activities for their age group. For social 
skills, 90.3% of patients believed that their social life was sufficient and normal for their 
age group. Although there was no separate T score for school, performance at school was 
included as part of the total competence score. For total competence, 80.6% of patients 
believed that they were considered normal.  
 
Figure 5: YSR categorical competence and behavioral results (N = 31).  
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 CBCL categorical behavioral problem results are displayed in Figure 4, while 
YSR categorical behavioral problem results are shown in Figure 5. For depression, 27.3% 
of parents believed that their child had some form of anxiety depression, and 15.2% of 
parents believed that their child had some form of withdrawal depression. While only 
16.2% of patients felt that they had some form of anxiety depression, but 19.4% of 
patients felt that they had some form of withdrawal depression. For somatic problems, 
81.8% of parents reported that their child was considered normal, and 96.8% of patients 
believed they were normal.  For social problems, 24.2% of parents believed that their 
child had some form of social difficulties, while only 9.7% of patients believe they had 
social difficulties. 24.3% of parents believed that their child had thought problems and 
only 16.1% of patients believe that they had an issue. 27.3% of parents believed that their 
child had attention issues, while only 6.5% of patients believe that they had trouble with 
paying attention. For rule breaking, there were no parents who thought that their child 
was intermediate, but 6.1% of parents believed that their child was clinical. For 
aggressive behavior, 9.1% of parents believed that their child was clinical or 
intermediate. Lastly, only 3.2% of patients believed that they had any rule breaking 
problems or aggressive behavior. Internalizing issues included both depression scores and 
somatic problems, and 36.4% of parents believed that their child was suffering from 
internalizing problems, while only 25.8% of patients believe they were suffering from 
internalizing problems. As for externalizing issues, this category included rule breaking 
and aggressive behavior, and 24.3% of parents believed that their child was suffering 
from externalizing problems, while only 9.7% of patients believed they were suffering 
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from externalizing problems. For total behavioral categorical scores, only 60.6% of 
parents believed that their child was considered normal, while 80.7% of the patients 
believed they were normal.  
  
Concordance Frequency 
 From the results in Table 2, the most concordance between parent and child was 
on externalizing behavior, with 80% of parents and patient agreeing with one another. 
Whereas the most discordance between parent and child was on internalizing behavior, 
with only 60% of parents and patient agreeing with one another.  
 
 Table 2: Concordance frequency table (N = 25).  
 Frequency 
(n/total) 
Percent 
Anxiety Depression 18/25 72% 
Withdrawn Depression 18/25 72% 
Total Competence 19/25 76% 
Internalizing 15/25 60% 
Externalizing 20/25 80% 
Total Score 17/25 68% 
 
Patient Demographics and Discordance  
 As shown in Table 3, there was significance between anxiety depression and 
paternal age. With increasing paternal age, there was more discordance between the 
parents’ and child’s views on the child’s anxiety depression.  
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Table 3: Difference of means between patient demographics and discordance.    
Domain Demographic 
 
Concordance 
(years) 
Discordance 
(years) 
P value 
Anxiety 
Depression 
Paternal age 36.41±5.185 42.43±5.94 0.021 
Externalizing 
Behavior 
Age when starting 
Arimidex 
14.47±1.727 12.25±1.5 0.032 
 
 We also found significance between age when starting Arimidex and 
externalizing concordance, shown in Table 3. When starting Arimidex later, there was 
more concordance between the parents’ and child’s views on the child’s externalizing 
behavior. Externalizing behavior included aggressive behavior and rule-breaking 
behavior.  
 
Correlation Between Demographics and CBCL/YSR Scores 
 We also ran Pearson correlation tests on demographics versus raw concordance 
scores for all domains of competence and behavioral scores. In Table 4, we found 
significance and a positive correlation between maternal age and adult social percentage 
as well as T score. With increasing maternal age, adult social percentage and T scores 
were higher, which indicated that the child’s social life was more fulfilling as reported by 
the parents.  
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Table 4: Pearson correlation tests between demographics and raw concordance scores 
Domain Demographic Correlation P value 
CBCL Social % Score Maternal age 0.387 0.031 
CBCL Social T Score Maternal age 0.375 0.037 
CBCL Withdrawn 
Depression T Score 
Age when starting 
Testosterone 
0.381 0.029 
 
 We also found significance and a positive correlation between the patient’s age 
when starting testosterone and adult withdrawn depression T score, shown in Table 4. 
With increasing patient age at the start of taking testosterone, adult withdrawn depression 
T score was higher. This implied that the child had some form of withdrawal depression 
as viewed by the parents. 
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DISCUSSION 
 	 The goal of this study was to collect clinical data that would help us analyze 
behavioral phenotypes in males with Klinefelter syndrome (KS)(47, XXY). We wanted 
to compare our data with earlier reports in the literature, and we were also interested in 
examining the parents’ view on their child’s upbringing and how it differed from the 
child’s own self-reflection. Our patient cohort encompassed mostly adolescents who were 
transitioning into college life or entering the work force. We wanted to be able to show 
that these patients, who started testosterone and aromatase inhibitors when they were in 
their early adolescent years, could successfully support themselves in the “real world” 
despite being diagnosed with Klinefelter syndrome. To our knowledge, this is the first 
chart review study that involves a wide age range of males with KS. The current study 
extends previous findings by providing data on how early hormonal intervention, with 
testosterone and aromatase inhibitors, improves the outlook of these patients’ lives in 
terms of overall competence and behavioral aspects. These findings support other studies 
by confirming a link between hormonal treatment and neurodevelopmental outcome in 
boys with KS (Mandoki et al., 1991; Patwardhan et al., 2002; Ross et al., 2005, 2009; 
Samango-Sprouse et al., 2012). This study not only correlates various demographic areas 
with different competence and behavioral aspects, but also expands on the psychological 
relationship between parents and child.   
 In our study, the majority of answers for the CBCL and YSR were normal. These 
results are similar to previous KS studies that utilized the same standardized instrument 
(Ross et al., 2012). Our study differs when looking at the CBCL total competence scores. 
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The total competence score evaluates social skills with peers and family members, 
success in school work, and the number of activities in which the child participates. 
Comparison of the percentile averages for CBCL/YSR activities and CBCL/YSR social 
skills showed that they were similar with scores of 81.8%/87.1% and 78.8%/90.3%, 
respectively. The only aspect that was not comparable between the two questionnaires 
was school work, as the YSR did not include a separate section to calculate the percentile 
and T score for this category. It is evident that many parents believed their son was 
struggling in classes because close to 40% of them considered their child to be either 
clinical or intermediate in this area. This score, in turn, shifted the CBCL total 
competence score so that the majority of parents believed that their child’s total 
competence was either clinical or intermediate.   
 These results may reflect how parents have unrealistic academic expectations for 
their child. Based on information from the EMRs, the patients in our study were 
achieving mainly A’s and B’s in their classes. These grades are considered above average 
by most educators. Whereas some parents may perceive a B as above average results, 
others may see it as only average or even below average. When evaluating this data, we 
must take into account how differing views of success can shape how the parents and 
child answer their respective questionnaires.  
 Previous studies have stated that many adolescents report feeling worse after 
stopping anastrazole, specifically Arimidex, in terms of their ability to concentrate and 
their overall energy level (Samango-Spouse et al., 2015; Wosnitzer et al., 2013). Our 
study confirms this observation because we found an overall reduction of aggression and 
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rule-breaking behavior in adolescents with KS who had early hormonal intervention. We 
also found that there was a significant difference between the patient’s age when he first 
started anastrazole, specifically Arimidex, and concordance between CBCL and YSR on 
externalizing behavior. When patients started Arimidex at a later age, the parents and 
child agreed more on the patient’s externalizing behavior. These results may simply 
reflect that the patient is older, more self-aware and can accurately evaluate his 
aggressive behavior or rule-breaking behavior. On the other hand, patients who are 
younger may simply not understand that this type of behavior is unacceptable or may not 
be aware that they are exhibiting aggressive/rule-breaking behavior. Further research is 
needed to make an evidence-based recommendation about optimal indications and 
duration of aromatase inhibitor therapy.  
 We also found that there was concordance between the age of the father when the 
child was born and anxiety depression scores. If the father was younger when the child 
was born, there was more agreement on the child’s anxiety depression. These results 
could be due to younger fathers being more energetic and willing to spend more time 
doing activities with his son. By spending more time with his child, the father may be 
able to detect whether his son exhibits signs of anxiety depression and may be able to 
accurately evaluate his son’s behavior. Alternatively, this could reflect that younger 
generations recognize anxiety and depression as a disease, and would encourage their 
child to get help, as opposed to hiding the condition.  
 Our study also confirms that early hormonal intervention was associated with 
improved behavioral outlook for patients with KS. Previous studies have shown that there 
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were no adverse outcomes related to TRT. The treatment was safe and effective in 
adolescents with KS and was not associated with suppression of serum LH or FSH 
(Mehta et al., 2014; Wosnitzer et al., 2013). In our study, there was a positive correlation 
between the age of the patient when he first began taking testosterone and the CBCL 
withdrawn depression score. Higher withdrawn depression scores signify that the child is 
more likely to be clinically depressed; therefore, our study showed that the later the 
patient started taking testosterone, the more likely he was to have a form of withdrawal 
depression. Future studies can elaborate on this aspect by having a randomized control 
trial with a larger, more varied cohort and a control group to truly see if taking 
testosterone at a later age will change the parents’ view on their child’s withdrawn 
depression.  
 In addition, we discovered a positive correlation between maternal age and CBCL 
social skill percentile and T score. This correlation implies that if the mother was older 
when the son was born, the parents perceived the adolescent as having a more fulfilling 
social life. These results may reflect that an older mother has a more established career, 
more time to spend with her child, and more resources to provide for her child because of 
a larger yearly income compared with a younger mother. This in turn may facilitate a 
more positive social environment for the child. On the other hand, these results could also 
simply show that older mothers can perceive and report their child’s social functioning 
differently from younger mothers.  
 There are limitations to this study that should also be taken into consideration. 
The decision to receive early hormonal replacement was made on an individual basis, 
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exclusively between parents and their urologist. Although the SES and educational 
characteristics of the families were similar because of the location of the clinic, there may 
be confounding factors that we were unable to account for, resulting in skewed data and 
more positive results. Important factors that were not consistently controlled in the 
current study include the amount of special education or tutoring that some KS children 
might have had, whether they had received hormonal treatment before coming to Weill 
Cornell Medicine, and their sensitivity to testosterone and anastrazole. Despite the strong 
associations between early hormonal treatment and positive behavioral, educational, and 
social outcomes in this study, causal relationships were unable to be drawn, particularly 
given the retrospective design of this study. As a result, these factors support the need for 
continued research into the impact of early treatment interventions in males with KS.  
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CONCLUSION 
 KS is the most frequent chromosomal abnormality in males, general practitioners 
should be aware of the various physical, cognitive, and behavioral phenotypes that are 
associated with this genetic disorder. Through early detection and appropriate 
management of low testosterone associated with KS, there is potential to have physical 
and behavioral benefits along with the improvement of general health, pubertal 
progression, academic progress, and social integration. Future KS studies will need to 
focus on identifying the underlying factors that contribute to the variability and severity 
of behavioral symptoms. These studies will help support the continuing development of 
evidence-based treatments for the KS population.  
Our investigation on early hormonal intervention in KS males is important for 
several reasons. The findings demonstrate an improvement in neurologic progression in 
behavioral areas that are of importance and commonly associated in boys with KS. The 
work amplifies the significance of early detection and treatment in a disorder that is 
severely under-diagnosed throughout the world. The findings also show that the desire of 
parents for their child to do well in school may affect their opinions on how their child is 
actually performing. In addition, the results establish that in terms of school grades, the 
definition of success is relative, and reality may differ from what is actually reported. 
Finally, our study touches upon a correlation between parental age when having their 
child and various behavioral and competence scores. Future studies can more thoroughly 
investigate this factor by increasing patient cohort size as well as creating more 
homogeneity within the patient sample, such as socioeconomic background and parental 
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education. This will minimize confounding effects on developmental scores and 
maximize the ability to further understand the link between treatment, parental age, and 
neurodevelopmental outcome. 
There has been consistent evidence from this study and others that indicate early 
diagnosis and management through hormonal intervention can mimic the normal 
progression of puberty for adolescents with KS and can be beneficial to the overall well 
being of these children. There are still challenges with determining the endocrinological 
management of KS, such as understanding the ideal hormonal levels to facilitate optimal 
physical and neurobiological development. With improved knowledge of the molecular 
mechanisms that lead to hypogonadism, investigators will be able to plan and execute a 
randomized prospective clinical trial, which will develop ideal treatment regimens for 
males with KS in the future.	
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